15th CPHI & PMEC India showcases pharma machineries, equipment, ingredients and technologies
The shows provide an opportunity to all stakeholders to discuss the entire range of pharma machinery, analytical instruments,…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
CphI & P-Mec India
14th CPhI & P-MEC India Expo all set to be held in Noida from 24th to 26th November
Identifying opportunities and building partnerships with this year’s hybrid ‘CPhI P-MEC India Virtual Conference’ is the highlight…
CMOs will account for four of five top bio-manufacturing capacities in 2025: CPhI Worldwide Report
230 COVID-19 supply agreements known, with demand for larger biocapacity remaining constrained as a consequence of the circa 1,000…
The Year That Was
Express Pharma (May 15-31, 2017) EXPANDING ACCESS Express Pharma has always taken a keen interest in India’s progress in the…
Pharma industry witnesses 68 deals in October 2017
Deal value decreases to $7.1 billion when compared five months average of $10.6 billion
New diabetes therapeutics to steal ground from insulin therapies: GBI Research
Increased market diversification is expected due to patent expiries for major insulin products
FDA approves Roche drugs for rare types of blood, lung cancers
The drug is already approved for patients who have been treated with Pfizer's lung cancer drug Xalkori
Crohn’s Disease diagnosed incident cases set to increase in the 7MM to 2026
The burden of diagnosed Crohn’s Disease (CD) is expected to grow between 2016 and 2026 in the seven major markets
Flexion’s Zilretta poised to shakeup knee osteoarthritis marketplace
The company anticipates a steady stream of novel therapies to enter the OA marketplace over the next 10 years
Affluent market, medical tourism to steer best-in line drug delivery devices in India
Trends indicate that medical tourism will also bolster the demand for sophisticated devices
Novartis seeks European approval for cell therapy Kymriah
The immunotherapy Kymriah is a key element of Novartis’s efforts to bolster its portfolio of oncology drugs
GSK gets boost for early cancer hopes with breakthrough status
The decision by the Food and Drug Administration paves the way for a speedy regulatory review of the BCMA drug for multiple…
Biotech firms race to recruit good bugs in war on cancer
Certain bacteria seem to help in cancer by priming immune cells and smoothing the path for immunotherapy drugs known as PD-1 drugs
Merck’s drug gets US FDA approval
The drug is expected to be available from December, was approved both as a tablet and an injection
Sandoz says new clinical data support two biosimilars
The trials shows the efficacy and safety of biosimilar adalimumab
Novartis posts eye drug data amid play for Eylea’s turf
The Basel-based drugmaker hopes this latest analysis lends RTH258 additional muscle when matched head-to-head with Eylea
J&J’s Stelara shows promise against lupus in study
J&J said the results were strong enough to advance Stelara into larger Phase III testing
‘We received an excellent reaction from the European market’
Suresh Pareek, MD, Ideal Cures, in an interaction with Express Pharma, talks about the uniqueness of INSTACOAT 4G, which was…
Risk-based monitoring: Gaining ground
Risk-based monitoring (RBM) adoption is building momentum as pharma companies and CROs are shifting focus and are developing…
Beyond just a filler – application of calcium phosphates in direct compression formulations
Daniel Zakowiecki, Marek Lachmann and Tobias Heß Chemische Fabrik Budenheim, in this article outlines the most important…